Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACXP
#4978
Acurx Pharmaceuticals, Inc. Common Stock
2.060
0
USD
+1.48%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.48%
Monthly Change
-46.07%
6 month change
+7.29%
Year Change
+7.29%
Previous Close
2.030
0
Open
2.060
0
Low
2.060
0
High
2.060
0
Volume
4
Markets
US Stock Market
Healthcare
ACXP
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Cash from operating activities
-2.25 M
-2.05 M
-1.67 M
-1.88 M
-1.18 M
-6.79 M
Cash from investing activities
—
—
—
—
—
—
Cash from financing activities
194.55 K
2.99 M
3.09 M
1.72 M
2.83 M
10.64 M
Free cash flow
-2.25 M
-2.05 M
-1.67 M
-1.88 M
-1.18 M
-6.79 M
News
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript
Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress
Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch
What's Going On With Acurx Pharmaceuticals Stock Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)
Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Acurx Pharmaceuticals (NASDAQ:ACXP)
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?
Acurx Pharmaceuticals, Inc. (ACXP) Q3 2025 Earnings Call Transcript
Acurx’s ibezapolstat shows microbiome-sparing properties in trials
Acurx Pharmaceuticals granted Australian patent for antibiotics